Synthesis and Characterization of N-Nitroso-3-morpholinosydnonimine as NO Radical Donor
Abstract
:1. Introduction
2. Results and Discussion
3. Materials and Methods
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Abdualkader, A.M.; Taher, M.; Yusoff, N.I.N. Mesoionic Sydnone: A Review in their Chemical and Biological Properties. Int. J. Pharm. Pharm. Sci. 2017, 9, 1–9. [Google Scholar] [CrossRef]
- Cherepanov, I.A.; Moiseev, S.K. Recent Developments in the Chemistry of Sydnones and Sydnone Imines. Adv. Heterocycl. Chem. 2020, 131, 49–164. [Google Scholar] [CrossRef]
- Zerbib, S.; Khouili, M.; Catto, M.; Bouissane, L. Sydnone: Synthesis, Reactivity and Biological Activities. Curr. Med. Chem. 2023, 30, 1122–1144. [Google Scholar] [CrossRef] [PubMed]
- Hladíková, V.; Vánã, J.; Hanusek, J. [3+2]-Cycloaddition Reaction of Sydnones with Alkynes. Beilstein J. Org. Chem. 2018, 14, 1317–1348. [Google Scholar] [CrossRef] [PubMed]
- Decuypère, E.; Plougastel, L.; Audisio, D.; Taran, F. Sydnone–alkyne cycloaddition: Applications in synthesis and bioconjugation. Chem. Commun. 2017, 53, 11515–11527. [Google Scholar] [CrossRef] [PubMed]
- Holm, P.; Kankaanranta, H.; Metsä-Ketelä, T.; Moilanen, E. Radical Releasing Properties of Nitric Oxide Donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur. J. Pharmacol. 1998, 346, 97–102. [Google Scholar] [CrossRef] [PubMed]
- Groves, J.T. Peroxynitrite: Reactive, Invasive and Enigmatic. Curr. Opin. Chem. Biol. 1999, 3, 226–235. [Google Scholar] [CrossRef] [PubMed]
- Singh, R.J.; Hogg, N.; Joseph, J.; Konorev, E.; Kalyanaraman, B. The Peroxynitrite Generator, SIN-1, Becomes a Nitric Oxide Donor in the Presence of Electron Acceptors. Arch. Biochem. Biophys. 1998, 361, 331–339. [Google Scholar] [CrossRef] [PubMed]
- Kawase, M.; Sakagami, H.; Motohashi, N. The chemistry of bioactive mesoionic heterocycles. In Bioactive Heterocycles VII: Flavonoids and Anthocyanins in Plants, and Latest Bioactive Heterocycles II; Springer: Berlin/Heidelberg, Germany, 2009; pp. 135–152. [Google Scholar]
- Lehmann, J. Nitric oxide donors—Current Trends in Therapeutic Applications. Expert Opin. Ther. Pat. 2000, 10, 559–574. [Google Scholar] [CrossRef]
- Rosenkranz, B.; Winkelmann, B.R.; Parnham, M.J. Clinical Pharmacokinetics of Molsidomine. Clin. Pharmacokinet. 1996, 30, 372–384. [Google Scholar] [CrossRef] [PubMed]
- Masuda, K.; Imashiro, Y.; Kaneto, T. Studies on Mesoionic Compounds. I. Synthesis of 3-Dialkylaminosydnonimines. Chem. Pharm. Bull. 1970, 18, 128–132. [Google Scholar] [CrossRef]
- Masuda, K.; Kamiya, T.; Imashiro, Y.; Kaneko, T. Studies on Mesoionic Compounds. II. Synthesis of N-Acyl Derivatives of 3-Dialkylaminosydnonimines. Chem. Pharm. Bull. 1971, 19, 72–79. [Google Scholar] [CrossRef]
- Fun, H.-K.; Hemamalini, M.; Nithinchandra; Kalluraya, B. 2,3-Di bromo-3-(2-bromophenyl)-1-(3-phenyl sydnon-4-yl)propan-1-one. Acta Cryst. 2010, E66, o3094. [Google Scholar] [CrossRef]
- Fun, H.-K.; Hemamalini, M.; Nithinchandra; Kalluraya, B. 2,3-Di bromo-3-phenyl-1-(3-phenyl sydnon-4-yl)propan-1-one. Acta Cryst. 2011, E67, o814. [Google Scholar] [CrossRef]
- Fun, H.K.; Loh, W.S.; Nithinchandra; Kalluraya, B. 4-{2-[2-(4-Chlorobenzylidene)hydrazinylidene]-3,6-di hydro-2H-1,3,4-thiadiazin-5-yl}-3-(4-methoxyphenyl)sydnone. Acta Cryst. 2011, E67, o1175–o1176. [Google Scholar] [CrossRef]
- Goh, J.H.; Fun, H.K.; Nithinchandra; Kalluraya, B. 4-Formyl-3-p-tolylsydnone. Acta Cryst. 2010, E66, o1303. [Google Scholar] [CrossRef] [PubMed]
- Grossie, D.; Harrison, L.; Turnbull, K. 3-{5-Bromo-2-[(triphenyl phosphanylidene)amino] phenyl}-4,5-di hydro-1,2,3-oxa diazol-3-ylium-5-olate. Acta Cryst. 2013, E69, o1196. [Google Scholar] [CrossRef]
- Grossie, D.; Harrison, L.; Turnbull, K. Crystal structure of 4-(2-bromopropionyl)-3-phenyl sydnone. Acta Cryst. 2014, E70, o1165–o1166. [Google Scholar] [CrossRef]
- Feelisch, M.; Ostrowski, J.; Noack, E. On the Mechanism of NO Release from Sydnonimines. J. Cardiovasc. Pharmacol. 1989, 14, S13–S22. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Saffon-Merceron, N.; Lherbet, C.; Hoffmann, P. Synthesis and Characterization of N-Nitroso-3-morpholinosydnonimine as NO Radical Donor. Molbank 2024, 2024, M1886. https://doi.org/10.3390/M1886
Saffon-Merceron N, Lherbet C, Hoffmann P. Synthesis and Characterization of N-Nitroso-3-morpholinosydnonimine as NO Radical Donor. Molbank. 2024; 2024(4):M1886. https://doi.org/10.3390/M1886
Chicago/Turabian StyleSaffon-Merceron, Nathalie, Christian Lherbet, and Pascal Hoffmann. 2024. "Synthesis and Characterization of N-Nitroso-3-morpholinosydnonimine as NO Radical Donor" Molbank 2024, no. 4: M1886. https://doi.org/10.3390/M1886